Multiple simultaneous embolic cerebral infarctions 11 months after COVID-19

Rajiv Advani1,2, Torbjørn Austveg Strømsnes3,4, Espen Stjernstrøm5

  • 1Stroke Unit, Department of Neurology, Oslo University Hospital, Oslo, Norway.

Thrombosis Journal
|August 19, 2021
PubMed

Insights

A persistent coagulopathy following COVID-19 can lead to venous thromboembolism (VTE) and paradoxical cerebral emboli, even months after the initial infection. This case highlights a serious long-term complication of COVID-19.

Area of Science:

  • Neurology
  • Hematology
  • Infectious Diseases

Background:

  • The COVID-19 pandemic presents long-term health challenges.
  • COVID-19 associated coagulopathy is a potential complication.
  • Venous thromboembolism (VTE) and paradoxical cerebral emboli are serious manifestations.

Purpose of the Study:

  • To report a case of paradoxical cerebral emboli secondary to COVID-19 associated coagulopathy.
  • To highlight the persistent nature of coagulopathy post-COVID-19.
  • To underscore the risk of ischemic stroke in patients with patent foramen ovale.

Main Methods:

  • Case report of a 51-year-old male patient.
  • Presentation with multiple simultaneous embolic cerebral infarctions 11 months post-mild COVID-19.
  • Diagnostic workup included D-dimer levels, imaging, and patent foramen ovale (PFO) assessment.

Main Results:

  • Patient experienced pulmonary emboli in the subacute phase of COVID-19, treated with anticoagulation.
  • Presented 11 months later with cerebral infarctions of unknown etiology.
  • Diagnosis of paradoxical thromboembolic event suggested by PFO and elevated D-dimer.

Conclusions:

  • COVID-19 associated coagulopathy can persist for months, leading to VTE.
  • The presence of a PFO increases the risk of ischemic stroke from COVID-19 related coagulopathy.
  • This case emphasizes the need to consider long-term thrombotic risks after COVID-19.
Abstract